Carallia
Carallia brachiata
Carallia brachiata is a plant traditionally not associated with any specific medicinal uses. The traditional medicine practices where it might be used are not well-documented. Scientifically, studies have focused on genetic and biochemical aspects of the plant. A study developed 11 polymorphic microsatellite markers for Carallia brachiata, which could aid in genetic research within its genus. Another study showed that leaf extracts from the plant can synthesize gold nanoparticles with varying morphologies and catalytic activity, indicating potential applications in nanotechnology or bioreduction processes. The complete chloroplast genome was sequenced, revealing a total length of 162,460 bp with 130 annotated genes, providing insights into its genetic makeup. No major safety issues have been recorded for the plant, and there are no reported drug interactions.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- The study developed 11 polymorphic microsatellite markers for Carallia brachiata, which will aid in genetic studies of the species and related genera.
- The study found that Carallia brachiata leaf extract could synthesize gold nanoparticles with varying morphologies and catalytic activity for reducing 4-nitrophenol.
- Carallia brachiata exhibited elevated levels of chlorophyll, anthocyanin, saponin, nitrogen, magnesium, and manganese.
- The complete chloroplast genome of Carallia brachiata was sequenced, revealing a total length of 162,460 bp with 130 annotated genes.
- The study found that (-)-(7''R,8''S)-buddlenol D and (-)-(7''S,8''S)-buddlenol D from Carallia brachiata inhibited nitric oxide and prostaglandin E2 production and suppressed p38 MAPK phosphorylation in macrophages.
Frequently asked questions
What is Carallia?
Carallia (Carallia brachiata) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Carallia?
5 sourced findings are recorded for Carallia; the strongest carries evidence grade D. For example: The study developed 11 polymorphic microsatellite markers for Carallia brachiata, which will aid in genetic studies of the species and related genera.
How strong is the evidence for Carallia?
The strongest finding for Carallia carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Carallia safe? What are the side effects?
No major safety issues are recorded for Carallia in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Carallia interact with medications?
No drug interactions are recorded for Carallia in our sources. This does not rule them out — check with a pharmacist.
What are the common names of Carallia?
Carallia is also known as: Караллия раскидистая.
Is Carallia a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Development of microsatellite markers for Carallia brachiata (Rhizophoraceae). literature abstract metadata
- T2 Biosynthesis of Gold Nanoisotrops Using Carallia brachiata Leaf Extract and Their Catalytic Application in the Reduction of 4-Nitrophenol. literature abstract metadata
- T2 In vitro and in silico studies of 7'',8''-buddlenol D anti-inflammatory lignans from Carallia brachiata as p38 MAP kinase inhibitors. literature abstract metadata
- T2 Characterization of the complete chloroplast genome of Carallia brachiata (Lour.) Merr. (Rhizophoraceae). literature abstract metadata
- T2 Nutritional profiling, bioactive phytochemicals, and functional food components of wild edible fruits from the Indo-Burma biodiversity hotspot. literature abstract metadata